# Optical Biopsy to Improve the Diagnosis of Kidney Cancer

> **NCT02073110** · — · UNKNOWN · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 194 (estimated)

## Conditions studied

- Kidney Cancer

## Interventions

- **DEVICE:** Percutaneous Optical Biopsy (OCT and DRS)

## Key facts

- **NCT ID:** NCT02073110
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-08
- **Primary completion:** 2016-12
- **Final completion:** —
- **Target enrollment:** 194 (ESTIMATED)
- **Last updated:** 2014-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02073110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02073110, "Optical Biopsy to Improve the Diagnosis of Kidney Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02073110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*